ESMO Sarcoma and Rare Cancers | Unanswered questions in managing medulloblastoma

Enrico Franceschi, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy, Bologna, Italy, describes unmet needs in the management of medulloblastoma, including overcoming resistance to current therapies by targeting Wnt activation. Prof. Franceschi additionally highlights the need to develop strategies for preserving fertility in patients post-treatment, as well as the need for further research in disease biology. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.